The new HTA guides 2017 could be up to their predecessors

From the first reports, back in 1920, we have studied, recognized and documented the excess of events associated with arterial hypertension. This linear relationship between the level of blood pressure and the risk of stroke, is evident in all adults beyond age, sex or race, transforming high blood pressure into the highest target of global public health.

Las nuevas guías Europeas de Hipertensión contrastan con las Americanas

The greatest impact of reducing hypertension was observed in adults between 60 and 74 years, where a decrease in systolic pressure from 148 to 129 mm Hg led to a 50% reduction in stroke risk, and a decrease from 188 to 156 mm Hg to a reduction of 90% of the risk!


Read also: New High Blood Pressure Guidelines.


These lower levels of blood pressure observed were, obviously, thanks to the pharmacological treatment of this age group. However, lower levels were also observed in the group between 20 and 29 years, which suggests that prevention and non-pharmacological treatment are also very effective.

From the end of the 90s until 2017, the evidence from randomized clinical studies and epidemiological studies was incorporated into the guidelines to detect, treat, control and prevent hypertension in the most effective way possible.

With each new guide that redefined objectives and improved treatment protocols, a decrease in the population’s blood pressure and a reduction in stroke risk was observed. These improvements cannot be attributed to the guidelines themselves, but rather to the implementation by doctors of their recommendations in daily clinical practice.


Read also: Patients with Resistant Hypertension: Nearly 50% doesn’t take medication.


The reduction in the risk of stroke due to the decrease in blood pressure has been proposed as the greatest achievement of public health in the last 50 years. This achievement is not more than the result of the application in daily clinical practice of recommendations based on evidence and adherence to treatment by patients.

We hope that the ambitious recommendations of the new hypertension guidelines of 2017 can continue with the trend of their predecessors, since there is still a huge potential in improving the cerebrovascular health of the population.

Original title: Implications of New High Blood Pressure Guidelines for Stroke Primary and Secondary Prevention.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....